These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 21729761)
61. Monitoring peak expiratory flow could predict COPD exacerbations: A prospective observational study. Cen J; Ma H; Chen Z; Weng L; Deng Z Respir Med; 2019 Mar; 148():43-48. PubMed ID: 30827473 [TBL] [Abstract][Full Text] [Related]
62. Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality - The STATUETTE Cohort Study. Damkjær M; Håkansson K; Kallemose T; Ulrik CS; Godtfredsen N Int J Chron Obstruct Pulmon Dis; 2021; 16():579-589. PubMed ID: 33707941 [TBL] [Abstract][Full Text] [Related]
63. Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids. Huang YJ; Kao S; Kao LT; Chian CF; Chung CH; Chien WC; Wang KY Int J Chron Obstruct Pulmon Dis; 2021; 16():591-602. PubMed ID: 33716501 [TBL] [Abstract][Full Text] [Related]
64. Prediction of gold stage in patients hospitalized with COPD exacerbations using blood neutrophils and demographic parameters as risk factors. Chen J; Yang Z; Yuan Q; Guo LQ; Xiong DX BMC Pulm Med; 2021 Oct; 21(1):329. PubMed ID: 34674678 [TBL] [Abstract][Full Text] [Related]
65. Statins, systemic inflammation and risk of death in COPD: the Rotterdam study. Lahousse L; Loth DW; Joos GF; Hofman A; Leufkens HG; Brusselle GG; Stricker BH Pulm Pharmacol Ther; 2013 Apr; 26(2):212-7. PubMed ID: 23142156 [TBL] [Abstract][Full Text] [Related]
66. Predictors of one-year mortality after hospitalization for an exacerbation of COPD. Esteban C; Castro-Acosta A; Alvarez-Martínez CJ; Capelastegui A; López-Campos JL; Pozo-Rodriguez F BMC Pulm Med; 2018 Jan; 18(1):18. PubMed ID: 29370849 [TBL] [Abstract][Full Text] [Related]
67. Statin Effects on Exacerbation Rates, Mortality, and Inflammatory Markers in Patients with Chronic Obstructive Pulmonary Disease: A Review of Prospective Studies. Howard ML; Vincent AH Pharmacotherapy; 2016 May; 36(5):536-47. PubMed ID: 26990316 [TBL] [Abstract][Full Text] [Related]
68. Hospitalization due to exacerbation of COPD: "Real-life" outcomes. Camargo LACDR; Castellano MVO; Ferreira FC; Faria FV; Carvas N Rev Assoc Med Bras (1992); 2017 Jun; 63(6):543-549. PubMed ID: 28876432 [TBL] [Abstract][Full Text] [Related]
69. Multi-level differential network analysis of COPD exacerbations. Noell G; Cosío BG; Faner R; Monsó E; Peces-Barba G; de Diego A; Esteban C; Gea J; Rodriguez-Roisin R; Garcia-Nuñez M; Pozo-Rodriguez F; Kalko SG; Agustí A Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28954781 [TBL] [Abstract][Full Text] [Related]
70. Using the Electronic Nose to Identify Airway Infection during COPD Exacerbations. Shafiek H; Fiorentino F; Merino JL; López C; Oliver A; Segura J; de Paul I; Sibila O; Agustí A; Cosío BG PLoS One; 2015; 10(9):e0135199. PubMed ID: 26353114 [TBL] [Abstract][Full Text] [Related]
71. Morphometric analysis of mitochondria in lymphocytes of patients with exacerbations of chronic obstructive pulmonary disease - pilot study. Białas AJ; Liberski PP; Zielińska A; Kumor-Kisielewska A; Szewczyk K; Miłkowska-Dymanowska J; Sitarek P; Piotrowski WJ; Górski P Int J Chron Obstruct Pulmon Dis; 2018; 13():2313-2318. PubMed ID: 30104871 [TBL] [Abstract][Full Text] [Related]
72. Coding of COPD Exacerbations and the Implications on Clinical Practice, Audit and Research. Echevarria C; Steer J; Bourke SC COPD; 2020 Dec; 17(6):706-710. PubMed ID: 33169617 [TBL] [Abstract][Full Text] [Related]
73. Resting Borg score as a predictor of safe discharge of chronic obstructive pulmonary disease from the emergency department observation unit. Sengupta R; Loftus TM; Doers M; Jandarov RA; Phillips M; Ko J; Panos RJ; Zafar MA Acad Emerg Med; 2020 Dec; 27(12):1302-1311. PubMed ID: 32678934 [TBL] [Abstract][Full Text] [Related]
74. Effects of ambient benzene and toluene on emergency COPD hospitalizations: A time series study in Hong Kong. Ran J; Sun S; Yang A; Yang L; Han L; Mason TG; Chan KP; Li J; Tian L Sci Total Environ; 2019 Mar; 657():28-35. PubMed ID: 30530216 [TBL] [Abstract][Full Text] [Related]
75. Association Between Rome Classification Among Hospitalized Patients With COPD Exacerbations and Short-Term and Intermediate-Term Outcomes. Crisafulli E; Sartori G; Huerta A; Gabarrús A; Fantin A; Soler N; Torres A Chest; 2023 Dec; 164(6):1422-1433. PubMed ID: 37516272 [TBL] [Abstract][Full Text] [Related]
76. Physical, Psychological, and Social Factors Associated with Exacerbation-Related Hospitalization in Patients with COPD. Crutsen MRC; Keene SJ; Nakken DJAJN; Groenen MT; van Kuijk SMJ; Franssen FME; Wouters EFM; Spruit MA J Clin Med; 2020 Feb; 9(3):. PubMed ID: 32120911 [TBL] [Abstract][Full Text] [Related]
77. Can the Rome classification of chronic obstructive pulmonary disease exacerbation severity be applied in the hospital setting? Cometa M; Ursitti A; Lombardo LP; Rana R; Gardani A; Contoli M; Papi A Respir Med; 2024 Feb; 222():107509. PubMed ID: 38145723 [TBL] [Abstract][Full Text] [Related]
78. Therapeutic effects of statins drugs use and continuous nursing on patients with chronic obstructive pulmonary disease and the influence of life quality. Weina J; Yanhua L; Jian W; Yan S Pak J Pharm Sci; 2018 May; 31(3(Special)):11794-1184. PubMed ID: 29735471 [TBL] [Abstract][Full Text] [Related]
79. Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study. Adir Y; Hakrush O; Shteinberg M; Schneer S; Agusti A ERJ Open Res; 2018 Jul; 4(3):. PubMed ID: 30083552 [TBL] [Abstract][Full Text] [Related]
80. A pilot study of daily telemonitoring to predict acute exacerbation in chronic obstructive pulmonary disease. Miłkowska-Dymanowska J; Białas AJ; Obrębski W; Górski P; Piotrowski WJ Int J Med Inform; 2018 Aug; 116():46-51. PubMed ID: 29887234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]